Prideapplication/xmlftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/03/PXD060410/180905_CAA4_P20_15_CAA_03_05.rawftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/03/PXD060410/200212_LB206_34_PA_FA_frontal_01_04.rawftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/03/PXD060410/200212_LB206_34_PA_FA_frontal_31_66.rawftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/03/PXD060410/200212_LB206_34_PA_FA_frontal_06_28.rawftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/03/PXD060410/180905_CAA4_P85_17_CAA_02_03.rawftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/03/PXD060410/180905_CAA4_P11_05_SCAA_11_08.rawftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/03/PXD060410/peptides_1_1_0.mzidftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/03/PXD060410/180905_CAA4_P20_15_CAA_03_05.mgfftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/03/PXD060410/180905_CAA4_P11_05_SCAA_11_08.mgfftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/03/PXD060410/200212_LB206_34_PA_FA_frontal_31_66.mgfftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/03/PXD060410/200212_LB206_34_PA_FA_frontal_06_28.mgfftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/03/PXD060410/200212_LB206_34_PA_FA_frontal_01_04.mgfftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/03/PXD060410/180905_CAA4_P85_17_CAA_02_03.mgfprimaryOK200jh@gu.seJörg HanriederData-dependent acquisitionMass SpectrometryNot availableHumanBrainLc-ms/mshttps://www.ebi.ac.uk/pride/archive/projects/PXD060410BrainFresh frozen cerebral tissue (90–110 mg pieces, consisting of both grey and white matter) was homogenized in 600 μl tris(hydroxymethyl)aminomethane (Tris)-buffered saline (TBS), pH 7.6, containing cOmplete (cat: 04693116001, Roche) protease inhibitor, using one 5 mm bead per sample in a TissueLyser (Qiagen) for 4 min at 30 Hz. To the the homogenate(~700 µl), 400 μl TBS with inhibitor was further added and transferred to a new tube, and centrifuged at 31,000 g for 1 h at +4℃. The supernatant (TBS fraction) was transferred to a new tube and stored at −80℃ until further use. The pellet was resuspended in 1 ml of 70% FA (v/v), followed by further homogenization in the TissueLyser for 2 min at 30 Hz and subsequent sonication for 30 s. The homogenate was centrifuged again at 31,000 g for 1 h at +4℃ and the supernatant (FA fraction) was dried down in a vacuum centrifuge. Prior to IP, the dried FA fractions were reconstituted in 200 μl 70% FA (v/v), shaken for 30 min at room temperature 21°C, and centrifuged at 31,000 g for 1 h at +4℃. The supernatant was removed and neutralized with 4 ml 0.5 M Tris. IP was performed as previously described with some modifications (Gkanatsiou et al., 2019). Briefly, the neutralized FA fraction was incubated overnight at +4℃ in 0.2% Triton X-100 in PBS (v/v) with a total of 50 µl IgG-coated magnetic beads (Dynabeads M-280 Sheep anti-mouse, cat: 11202D, Thermo Fisher Scientific) that had previously been linked with 4 µg each of mouse monoclonal 6E10 and 4G8 (cat: 803003 and 800711, Biolegend) per sample. By using an automated magnetic-particle KingFisher ml system (Thermo Fisher Scientific), the samples were then washed with PBS Triton X-100, PBS, and 50 mM ammonium bicarbonate separately before elution in 100 µl 0.5% FA. Eluates were dried down in a vacuum centrifuge and stored at −80℃ pending MS analysis. As a negative control experiment, the anti-Aβ antibodies were substituted with anti-neurogranin antibodies. Prior to MS analysis, samples were reconstituted in 5 μl 0.1% FA/20% acetonitrile in water (v/v/v). Analysis was performed using a Bruker Daltonics UltraFleXtreme matrix-assisted-laser-desorption/ionization-time-of-flight/time-of-flight (MALDI-TOF/TOF) instrument. MALDI samples were prepared using the seed layer method as previously described (Gkanatsiou et al., 2019). An average of 10,000 shots was acquired for each spectrum (2,000 at a time using a random walk mode).PrideNot availableFor the LC-MS acquisitions, database search (including isotope and charge deconvolution) was performed with PEAKS Studio v8.5 (Bioinformatics Solutions Inc.) against a custom-made APP database. For the synaptic biomarkers, Skyline 20.1 (MacCoss Lab Software) was used for data processing and to calculate peak areas; all peaks were inspected manually. Synaptic protein ratios were recalculated to concentrations using the standard concentrations added to each sample and then normalized against brain tissue mass.ProteomicsJörg HanriederDepartment of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, SE-431 80 Mölndal, SwedenCOMPLETEHomo Sapiens (human)Not availablejh@gu.seUniversity of GothenburgSweden10.6019/PXD060410Water, MeCN, Laser Desorption-Ionization Mass Spectrometry, Laboratory, domestic sheep, H(2)O, FEZL, Octoxinols, Triton X305, BOUND WATER, Lasers, oxidane, Trisamine, House Mouse, 3-Propanediol, prevention, Long Term, WATER, HOH, CNS tracts and commissures, sal1, domestic cat, Domestic Cats, Gamma Globulin, Method, Protease Inhibitor, CH3-C#N, 1, 3, 2210418N07, bacterial catalase-peroxidase activity, ASD2, Octoxynol-9, average, CT21282, Tissue, MS-MALD, HardwareType, Plant Embryo, cell sheath, Shots, foot, Tri(hydroxymethyl)aminomethane, AI047805, Matrix Assisted Laser Desorption Ionization, haem catalase activity, HSAL1, Peptidohydrolase Inhibitor, (1 (5-nitro-2-furanyl)methyleneamino)tetrahydropyrimidine-2-one methanol cyclohexanocarboxylate, anatomical tube, sample, Octylphenoxy Polyethoxyethanol, sal-1, AI315345, equilase activity, preventive therapy, BZRP, Longterm Effect, Procedure, Ovis dalli, antibodies, Triton X100, not genetically inherited, A330009E03Rik, PBS, PBR, H2O, Dm1, Felis domestica, Hydrolase Inhibitor, numerical data, simple tissue, Imperforate anus with hand, Hydrogen Oxide, Sensorineural deafness with imperforate anus and hypoplastic thumbs, ACGNAT, Q-Switched Laser, oligonucleotide random primer, Antagonists, instrument, Swiss Mouse, Plant Zygote, Pulsed Laser, Methodological, Felis sylvestris catus, substantia alba, Painful bladder syndrome, antagonists and inhibitors, Matters, duct, GT, White, Mouse, Endopeptidase, Peptide Peptidohydrolase Inhibitor, 3-tetramethylbutyl)phenyl)-omega-hydroxy-, methyl cyanide, DROCATHPO, bs36h11.y1, Polyethoxyethanol, BPBS, Immunoglobulin, TBS1, Effects, Endopeptidase Inhibitors, abdominal muscles, 2-ethanediyl), CG7826, agua, CrAT, manganese catalase activity, TOF, Ovis ovis, Triton X 305, CG7835, CG42273, Mus musculus domesticus, Peptide Hydrolase, renal-Ear-anal-radial syndrome, Technique, ZNF312, ZNF794, RC3 Protein (Neurogranin), anatomical systems, Pulsed Lasers, 2310061K05Rik, Immunoglobulin GT, Longterm, Ovis, Zygote, pk18, Matrix Assisted, Long-Term, Antagonist, alpha-(4-(1, MBR, Sal-1, with hand, Study, DmelCG6871, Continuous Wave Laser, Q-Switched Lasers, Protease Antagonists, Triton X45, CNS white matter, PTBR, Peptide Peptidohydrolase Inhibitors, M-280, Tris(hydroxymethyl)aminomethane, MALD-MS, inhibitors, Elaiosomes, DMCATHPO, use, heme catalase activity, 1-(14)C-labeled, Octoxinol, Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry, acetonitrile, deafness, Triton X 100, Experiment, Temperatures, Cerebellar White, Felis domesticus, chemical analysis, Long Term Effects, eagle-Barrett syndrome, dJ142L7.2, CS1, AU020952, wild sheep, prophylaxis, Polyglobin, Magnetic, Townes-Brocks syndrome 1, House Mice, CG6871, ethanenitrile, Childhood, Peptidohydrolase Inhibitors, Matrix-Assisted Laser Desorption-Ionization, mDRC, Longterm Effects, ME-IV, plan specification, Peptidase, ZFP312, Antiprotease, control, sheath of cells, Peptide Hydrolase Inhibitors, lambs, [OH2], Sheep, pyrene (narrow), IgG Antibody, Triton X-45, Endopeptidase Inhibitor, NCMe, determination, Mus domesticus, Triton X-305, instrument configuration, Trometamol, Peptide Hydrolase Inhibitor, Matrix Assisted Laser Desorption Ionization Mass Spectrometry, Matter, Domestic Cat, Cs-1, GRO:0005339, Poly(oxy-1, P17 Protein Kinase C Substrate, White Matter, Techniques, Ovis orientalis aries, Octoxynol 9, Inhibitors, Min, Hydrolase Inhibitors, Elaiosome, prevention and control, Effect, DmelCG42273, Surface Enhanced Laser Desorption Ionization Mass Spectrometry, seed, Maser, reference sample, TACHD, min, mAPC, Swiss Mice, IBP, Mass Spectrometry, MALDI MS, Domestic, imperforate, Cerebellar White Matter, Continuous Wave, preventive measures, Methodological Studies, Diaspores, dihydridooxygen, house mouse, Bladder pain syndrome, dihydrogen oxide, Long-Term Effects, catalase-peroxidase activity, Tube, Peptidase Inhibitor, white mater, statistics and numerical data, mouse, aqua, lamina, Dmel_CG7826, Q Switched Lasers, 2.3.1.7, Peptide Peptidohydrolase, Laser Desorption Ionization Mass Spectrometry, AI195249, Triton X-100, with imperforate anus and hypoplastic thumbs, Spectroscopy, Immunization, TUBE, catalase reaction, IgG3, IgG4, IgG1, IgG2, Seed, Cerebellar, GAT, Dmel_CG7835, Mnb, MNB, and Ear anomalies, Mus musculus, absence of, Diaspore, Painful Bladder Syndrome, Tris Buffer, IgG, znf794, mice, Sonications, White Matters, hydrogen-peroxide:hydrogen-peroxide oxidoreductase activity, hydrogen hydroxide, Plant, Dall Sheep, sall1a, AW124434, Felis silvestris catus, Methodological Study, acqua, domesticus, Townes syndrome, Ovis ammon aries, Cerebellar White Matters, Peptidase Inhibitors, Q-Switched, IgG2A, IgG2B, Antiproteases, Wasser, Laser, Inhibitor, U00145, 7S, Dall, Bladder Pain Syndrome, Cas1, Carnitine acetylase, MALDI-MS, Procedures, Protease, foot and ear anomalies, hardware, method, Antibody, Octoxynols, utilization, Octylphenoxy, House, Pulsed, method used in an experiment, Mass, Studies, Protease Antagonist, caperase activity, Masers, Mice, Mass Spectroscopy, REAR syndrome, IgG(T), Tris-Mg(II)-KCl Buffer, Swiss, layer, white matter, inhibiteur, CatA, CATA, Tris-Magnesium(II)-Potassium Chloride Buffer, eau, SELDI-TOF-MS, Cats, RANDOM, inhibidor, Octylphenoxypolyethoxyethanols, Catl, HEL-S-89, Zygotes, cats, Long-Term Effect, FEZ, sensorineural, Controlled, DYRK1, Controlling, bead, DBI, 3H-labeled, Felis catus, Continuous Wave Lasers, inhibitor, Carnitine acetyltransferase, Peptide, light amplification by the stimulated emission of radiation, with imperforate anus and thumb anomalies, TBS, Renal-ear-anal-radial syndrome, anus, PKBS, Mus, water, Embryos, AI551343, Dyrk1, Vacuums, Cat, CAT, ACETONITRILE, cyanomethane, optidase activity, antagonists, VSD1, Embryo, tbs, Cas-1, with urinary tract Abnormality and cryptorchidism, Triton X 45, Matrix-Assisted, Random selection by shearing., CC1, cat, Plant Embryos, sample population, sheep, Laboratory Mice, MALDI, Cat01, Plant Zygotes, Trizma, Townes-Brocks-branchiootorenal-like syndrome, 7S Gamma Globulin, layer of cells, Allerglobuline, assay, 2-amino-2-(hydroxymethyl)-, Laboratory Mousethe brain, liquid chromatography tandem mass spectroscopy, LC-MS2, other disease, human disease, suprasegmental structures, human being, LCMSMS, Man (Taxonomy), Modern, Encephalon, LC-MS/MS, disorders, Imaging, suprasegmental levels of nervous system, encephalon, human, LC-MS-MS, Human, non-neoplastic, disease, LC/MS/MS, Homo sapiens, diseases, liquid chromatography-tandem mass spectroscopy, Modern Man, LC-MSMS, Diseases, disease or disorder, liquid chromatography tandem mass spectrometry, condition, disorder, diseases and disorders, Homo sapiens disease, medical condition., synganglion, ManAmyloid intracellular domain 57, APP, ABETA, Amyloid intracellular domain 59, Biological Markers, Viral Marker, NK-2, Surrogate Endpoints, Laboratory, dhc64C, Liquid Chromatography Mass Spectrometry, nk-2, Biochemical, High Performance Liquid Chromatography Mass Spectrometry, A4, CTFgamma, Endpoint, NK2, Ultra Performance Liquid Chromatography-Mass Spectrometry, protein, Serum, Amyloid intracellular domain 50, Molecular Biologies, Abpp, High Performance Liquid Chromatography-Mass Spectrometry, AAA, Cvap, Laboratory Markers, CG42318, HPLC-MS, AG, Liquid Chromatography-Mass, Bio Informatics, Beta-amyloid protein 42, Biological, Fs(3)Laborc, dhc64c, Beta-amyloid protein 40, cDhc64C, WBSCR15, synganglion, Software Engineering, protein aggregate, AID(50), Computer Program, WMS, Dhc, DHC, Ultra Performance Liquid Chromatography Mass Spectrometry, Ag, Biology, Open, HDC16822, Tissue, Computer Programs and Programming, NTAL, EG:118B3.1, suprasegmental levels of nervous system, Bio-Informatic, Computational, EG:196F3.2, dhc, Alzheimer disease amyloid A4 protein homolog, CD, N-APP, Gamma-secretase C-terminal fragment 50, Immune, Markers, Gamma-secretase C-terminal fragment 57, Liquid Chromatography-Mass Spectrometries, Bio-Informatics, Gamma-secretase C-terminal fragment 59, Viral Markers, sample, AD1, Abeta, APPI, GPHYSD2, C80, l(1)RC24, Computational Molecular Biologies, SGS, C83, l(1)EA142, suprasegmental structures, Viral, AICD-50, Surrogate Endpoint, S-APP-alpha, VND, Vnd, Biologies, CG17144, Dhc46C, CR32097, Biochemical Markers, Fs(3)Sz18, Gamma-CTF(57), Biologic Marker, Computational Molecular, Source Softwares, Software Tools, Programs, ACMICD, C99, Program, Computer Applications, l(1)VE769, Marker, Dm vnd, l(1)EC6, Computational Molecular Biology, Computer Applications Software, AICD-57, Computer Applications Softwares, simple tissue, Softwares, CG14784, DHC64C, AICD-59, CG14783, Cerebral vascular amyloid peptide, Software Applications, Bioinformatic, End Points, High Pressure Liquid Chromatography Mass Spectrometry, Source Software, Encephalon, Spectrometry, cDhc, Dhc64, Immunologic, MASS, Alzheimer disease amyloid protein, Laboratory Marker, Protease nexin-II, Dmel_CG5620, data analysis, Applications, Su(Gl)77, Biochemical Marker, Dm-NK2, Liquid, HMW MAP, DmelCG32810, Computer Software Applications, the brain, DmelCG42318, Clinical Markers, P3(40), Clinical Marker, FBN, l(3)64Ca, Gene, Computer, betaApp, protein-containing complex, l(1)GA100, Surrogate End Points, AID(59), Surrogate Markers, Cdhc, dNK-2, ECTOL1, APP-C57, DmelCG7507, APP-C59, Gene Products, Dhc64c, Application, UPLC-MS, Biomarker, Open Source Softwares, Ultra-Performance Liquid Chromatography-Mass Spectrometry, Clinical, PreA4, Software Application, Biological Marker, Open Source Software, S-APP-beta, Spectrometries, Dmel_CG17144, CG5620, Gamma-CTF(59), EC6, HSPC046, Solution, l(1)GA122, Computer Software Application, OCTD, AID(57), Immunologic Markers, data processing, Tools, Lab, LAB, CG6172, Nkx2, Chromatography-Mass Spectrometries, Immunologic Marker, Biologic, Fs(3)Lab, WBSCR5, Applications Software, Open Source, Molecular Biology, Amyloidogenic glycoprotein, Computer Software, E030013M08Rik, lab, protein complex, Serum Markers, Proteins, End Point, High Pressure Liquid Chromatography-Mass Spectrometry, encephalon, Bioinformatics, CG7507, Immune Marker, Tool, Gamma-CTF(50), APP-C99, Isotope, Software Tool, native protein, l(1)1Bf, Surrogate End Point, l(1)VA208, Adap, Protein, vnd/NK-2, MFS1, Dynein, DmelCG6172, Software, Data Base, WMS2, Biologic Markers, P3(42), PN-II, Serum Marker, Surrogate, Endpoints, Engineering, Soluble APP-beta, Surrogate Marker, FCP-A, sample population, SSKS., C31, Protein Gene Products, Computer Programs, Gene Proteins, WBS15, Applications Softwares, Chromatography-Mass Spectrometry, Soluble APP-alpha, LC-MS, PN2, Beta-APP42, Beta-APP40, CG32810, CVAP, ABPP, Immune Markersthe brain, social phobia, fad, Dalpha, GLM3, Dalpha2, CG5887, ted, tmp, Amyloid Fibril, CG5925, Seasonal Affective Disorder, peptide, Polypeptides, Dalpha2/SAD, alpha[[2]], systemic amyloidosis, peptido, childhood separation anxiety, amyloid, CG2262, Da2, synganglion, FANCD1, social anxiety disorder, BROVCA2, alpha2, FA-D2, desat2/Fad, adult separation anxiety disorder, DSmad2, amyloidosis, Senile Plaque, Amyloid Plaque, Acr96Ab, FAD1, desatF, peptides, FAD2, BRCC2, BB137857, nAchRalpha-96Ab, nAChR Dalpha2, amyloidosis (disease), CG7923, smad2, da2, Substance, Riboflavin 5'-(trihydrogen diphosphate), suprasegmental levels of nervous system, Amyloid, Flavitan, PNCA2, Neuritic Plaque, SMAD2, fad2, Amyloid Deposit, separation anxiety, desatF-alpha, FANCB, Flavin Adenine Dinucleotide, FANCD, CG6844, Adult-Onset Separation Anxiety Disorder, AD3, Smad2, separation anxiety in childhood, peptidos, desat, l(3)S028813, species, Senile Plaques, D[a2], FACD, Plaque, DmelCG2262, ds2, Senile, ds1, Alzheimer disease, Dinucleotide, suprasegmental structures, CG6844-PA, Neuritic Plaques, PS1, familial, Amyloid Deposits, 7-11HD, encephalon, Peptide, S182, Deposit, BEST:SD05462, Amyloid Fibrils, polypeptide, Deposits, DmelCG5887, Experiment, DmelCG5925, Neuritic, anon-WO0118547.726, dSMAD2, P'-5'-ester with adenosine, l(1)G0348, DSMAD2, Seasonal depression, anon-WO0118547.730, Sad, SAD, XRCC11, dSmad2, amyloid disease, nAcRs, Fibril, AU015151, adult separation anxiety, 2410150O07Rik, PS-1, DmelCG6844, Amyloid Substance, amyloidoses, AcrE, nAChR, sad, FA4, dsmad2, Encephalon., Plaques, social anxiety, desat-2, Desat1, separation anxiety disorder, DmelCG7923, Desat2, SMOX, Fibrils, Children's separation anxiety, nAcr96Ab, FAD, Fad, Peptid, Polypeptide, Pediatric-Onset Separation Anxiety Disorder, childhood separation anxiety disorder, smox, Flavin-Adenine, Amyloid Plaques, GARD:0000632, Dmalpha2falseHuman brain LC-MS/MS for Chemical imaging delineates Aβ plaque polymorphism across the Alzheimer’s disease spectrumThe amyloid peptides in various types of amyloid plaques were studied from sAD, fAD and PA brains. This experiment was performed to identify the peptide species in brain samples.2025-03-202025-02-01PXD060410NEWT:330879NEWT:377960NEWT:1131NEWT:35795NEWT:2042546NEWT:259447NEWT:295546NCBITaxon:2719036NEWT:1334565NEWT:625351NEWT:258594NCBITaxon:1280NEWT:112503NEWT:1129NEWT:309807NEWT:59753NEWT:89184NEWT:309800NEWT:281395NEWT:1211601NEWT:876138NEWT:44271NEWT:193516NEWT:2315688NEWT:1073882NEWT:6819NEWT:112509NEWT:475174NEWT:111205NEWT:428386NEWT:1117NEWT:498257NEWT:10036NEWT:32264NEWT:12215NEWT:1590NEWT:10034NEWT:33114NEWT:1596NEWT:661410NEWT:638632NEWT:224326NEWT:376619NCBITaxon:79857NEWT:1096976NEWT:3765NEWT:3767NEWT:1589NEWT:135622NEWT:4615NEWT:672127NEWT:35786NEWT:1580NEWT:399784NEWT:96731NEWT:656064NEWT:1582NEWT:3760NEWT:1584NEWT:36630NEWT:1585NEWT:383379NEWT:418106NCBITaxon:12721NEWT:10029NEWT:913645NEWT:2492962NEWT:641809NEWT:1392488NEWT:38815NEWT:317447NEWT:4688NEWT:111225NEWT:7719NEWT:5530NEWT:868565NEWT:135674NEWT:79329NEWT:30069NEWT:12637NEWT:59729NEWT:2164133NEWT:295105NEWT:108061NEWT:60711NEWT:224308NEWT:3347NEWT:49928NEWT:3349NEWT:160621NEWT:212790NEWT:110368NEWT:55350NEWT:1310161NEWT:77133NEWT:145481NEWT:1310165NEWT:29058NCBITaxon:79824NEWT:1912919NEWT:410658NEWT:5516NEWT:44688NEWT:44689NEWT:498211NEWT:345076NEWT:347256NEWT:5518NEWT:398007NEWT:1527468NEWT:498217NEWT:498216NEWT:11320NEWT:246196NEWT:246197NEWT:145458NEWT:1310173NEWT:44685NEWT:161934NEWT:156587NEWT:1148NEWT:5508NEWT:3329NEWT:419481NEWT:5507NEWT:260499NEWT:410661NEWT:1140NCBITaxon:2157NEWT:2066563NEWT:1143NEWT:1287689NEWT:1094343NEWT:1462472NEWT:1336795NEWT:644042NEWT:150808NEWT:1182590NEWT:3712NEWT:3711NEWT:3714NCBITaxon:37162NEWT:270643NEWT:2065263NEWT:177437NEWT:717966NEWT:10891NEWT:10418NEWT:118698NEWT:1616117NEWT:118696NEWT:34865NEWT:52283NEWT:28174NEWT:284812NEWT:8175NEWT:43330NEWT:1603293NEWT:44664NEWT:43346NEWT:3702NEWT:1245466NEWT:3704NEWT:244366NEWT:1246791NEWT:176597NEWT:118694NEWT:2850NEWT:118691NEWT:34871NEWT:33548NEWT:52299NEWT:8165NEWT:96794NEWT:3708NEWT:332648NEWT:44670NEWT:926571NEWT:536231NEWT:376219NEWT:219813NEWT:1510NEWT:460519NEWT:1515NEWT:572307NEWT:1432138NEWT:1424507NEWT:1194599NEWT:272844NEWT:1348799NEWT:33995NEWT:55784NEWT:1303443NEWT:9483NEWT:485NEWT:56636NEWT:2709072NEWT:2499525NEWT:2853422NEWT:487NEWT:1538553NEWT:1679718NEWT:480NEWT:67767NEWT:45972NEWT:46835NEWT:109757NEWT:582580NEWT:1185650NEWT:216778NEWT:294607NEWT:1502NEWT:128017NEWT:2836NEWT:376686NEWT:237610NEWT:95486EFO:0001352NEWT:119562NEWT:1883446NEWT:1233435NEWT:118223NEWT:11757NEWT:987059NEWT:109760NEWT:29031NEWT:317047NEWT:1509NEWT:491NEWT:460523NEWT:45954NEWT:235443NEWT:1579NEWT:1757312NEWT:85694NEWT:109786NEWT:108458NEWT:5936NEWT:320637NEWT:1078283NEWT:3750NEWT:983964NEWT:11706NEWT:32644NEWT:527796NEWT:499175NEWT:109779NEWT:3745NEWT:1715989NCBITaxon:4751NEWT:3747NEWT:1116234NEWT:1255228NEWT:410289NEWT:191701NEWT:373153NEWT:1640278NEWT:472NEWT:940825NEWT:29459NEWT:529507NEWT:1071661NEWT:28128NEWT:470NEWT:5911NEWT:748693NCBITaxon:50557NEWT:39251NEWT:29491NEWT:101841NEWT:446NEWT:153481NEWT:2014887NEWT:33952NEWT:11723NEWT:445NEWT:153009NEWT:261756NEWT:166313NEWT:63366NEWT:63367NEWT:215402NEWT:1547NEWT:1290454NEWT:906914NEWT:81231006NEWT:28141NEWT:9031NEWT:27292NEWT:1050722NEWT:3728NEWT:108931NEWT:1293497NEWT:1055524NEWT:548NEWT:150475NEWT:267872NEWT:381666NEWT:172269NEWT:9534NEWT:2126348NEWT:5180NEWT:256737NEWT:9541NEWT:8694NEWT:33936NEWT:8692NEWT:2903NEWT:185579NEWT:872227NEWT:13076NEWT:2587410NEWT:207340NEWT:1006581NEWT:8673NEWT:33940NEWT:2126337NEWT:550NEWT:33941NEWT:554NEWT:451516NEWT:552NEWT:1325291NEWT:42410NEWT:36185NEWT:1054211NEWT:1225786NEWT:771870NEWT:51338NEWT:9995NEWT:575412NEWT:28112NEWT:49012NEWT:6493NEWT:10832NEWT:6494NEWT:6491NEWT:507601NEWT:520NEWT:64657NEWT:186441NEWT:643680NEWT:214092NCBITaxon:6157NEWT:13095NEWT:162425NEWT:104105NEWT:216257NEWT:9986NEWT:8654NEWT:8658NEWT:1268063NEWT:8657NEWT:9983NEWT:8655NEWT:5147NEWT:595495NEWT:28108NEWT:28104NEWT:407821NEWT:568703NCBITaxon:2NEWT:568708NEWT:1613NEWT:986NEWT:52641NEWT:28532NEWT:353152NEWT:298176NEWT:353153NEWT:227377NEWT:1774284NEWT:40674NEWT:1194669NEWT:51329NEWT:74426NEWT:443906NEWT:13037NEWT:519NEWT:2510939NEWT:7394NEWT:6063NEWT:1328388NEWT:105487NEWT:1548728NEWT:667127NEWT:9557NEWT:377586NEWT:300641NEWT:39655NEWT:9554NEWT:38323NEWT:475932NEWT:256318NEWT:206411NCBITaxon:6191NEWT:229533NEWT:214053NEWT:28550NEWT:80863NEWT:90675NEWT:52639NEWT:52638NEWT:57075NEWT:1666905NEWT:8697NEWT:861109NEWT:8695NEWT:884204NEWT:510516NEWT:1045775NEWT:1123869NEWT:9544NEWT:9545NEWT:979NEWT:7370NEWT:83906NEWT:99488NEWT:1134506NEWT:255470NEWT:38783NEWT:6426NEWT:33090NEWT:9935NEWT:287889NEWT:305959NEWT:1028307NEWT:13489NEWT:29829NEWT:92867NEWT:92866NCBITaxon:3055NEWT:51750NEWT:202950NEWT:441772NEWT:1293091NEWT:1867051NEWT:48106NEWT:202956NEWT:295027NCBITaxon:11320NEWT:632957NEWT:9925NCBITaxon:9606NEWT:90690NEWT:1436183NEWT:300273NEWT:4232NEWT:416348NEWT:11298NEWT:4236NEWT:7742NEWT:196627NEWT:1076878NEWT:200308NEWT:200302NEWT:870435NEWT:58370NEWT:9913NEWT:9915NEWT:105841NEWT:2666255NEWT:999810NCBITaxon:5693NEWT:28995NEWT:2144189NEWT:1392998NEWT:380394NEWT:1150621NEWT:226900NEWT:1266738NEWT:231490NEWT:244704NEWT:7725NEWT:9909NEWT:9902NEWT:430615NEWT:563041NEWT:72664NEWT:36599NEWT:41949NEWT:249161NEWT:326423NEWT:452467NEWT:198822NEWT:36111NEWT:326424NEWT:1678078NEWT:749906NEWT:418985NEWT:749907NEWT:150847NEWT:2023717NEWT:29835NEWT:1229733NEWT:431947NEWT:69014NEWT:142809NEWT:1095183NEWT:302409NEWT:130821NEWT:27606NEWT:290610NEWT:1519788NEWT:59202NEWT:9975NEWT:8643NEWT:1801631NEWT:1159899NEWT:502780NEWT:860688NEWT:13443NEWT:35231NEWT:1774208NEWT:8644NEWT:1125630NEWT:5141NEWT:46360NCBITaxon:3044782NEWT:202914NEWT:160235NEWT:502779NEWT:297246NEWT:103690NEWT:8639NEWT:1928434NEWT:8637NEWT:1114970NEWT:2096NEWT:285272NEWT:192222NEWT:9963NEWT:1617910NEWT:197911NEWT:197912NEWT:637379NEWT:12107NEWT:2785785NEWT:411901NEWT:1298722NEWT:8626NEWT:186801NEWT:105884NCBITaxon:9615NEWT:8621NEWT:58334NEWT:58331NEWT:6446NEWT:33038NEWT:8624NEWT:5116NEWT:6447NEWT:8623NEWT:5597NCBITaxon:3077NEWT:194439NCBITaxon:12637NEWT:38727NEWT:218496NEWT:420850NEWT:8618NEWT:70448NEWT:103695NEWT:300251NEWT:9945NEWT:9940NEWT:13451NEWT:1247190NEWT:118702NEWT:118700NEWT:2126719NEWT:118705NEWT:1079921NEWT:6945NEWT:72859NEWT:2104NEWT:2627626NEWT:6943NEWT:157546NEWT:870726NEWT:91374NEWT:91373NEWT:1414448NEWT:27804NEWT:474186NEWT:54195NEWT:10136NEWT:321803NEWT:38942NEWT:4762NEWT:6941NEWT:307972NEWT:2102NEWT:34NEWT:38949NEWT:1299114NEWT:1590841NEWT:60876NEWT:1276473NEWT:2282334NEWT:1247NEWT:70667NEWT:869728NEWT:6938NCBITaxon:39054NEWT:1885322NEWT:1736309NEWT:4751NEWT:36774NEWT:194963NEWT:860918NEWT:77298NEWT:15819NEWT:109461NEWT:1085956NEWT:6928NEWT:1239NEWT:36745NEWT:400727NEWT:272560NEWT:272563NEWT:11009NEWT:913998NEWT:68335NEWT:3885NEWT:3888NEWT:649408NEWT:6915NEWT:101510NEWT:3880NEWT:272559NEWT:216816NEWT:153151NEWT:2681598NEWT:1220NEWT:515849NEWT:10141NEWT:95767NEWT:466585NEWT:1000589NEWT:42192NEWT:85963NEWT:29NEWT:85962NEWT:42197NEWT:6918NEWT:681196NEWT:143361NEWT:1223501NEWT:5656NEWT:1292NEWT:1295NEWT:1299NEWT:424718NEWT:316407NEWT:1794699NCBITaxon:183674NEWT:167387NEWT:84645NEWT:1123294NEWT:6978NEWT:209285NEWT:211586NEWT:747078NEWT:1282NEWT:1283NEWT:1000561NEWT:253836NEWT:2133NEWT:6973NEWT:176279NEWT:294381NEWT:197NEWT:1390363NEWT:35889NEWT:406072NEWT:1454958NEWT:351660NEWT:29176NEWT:201319NEWT:1073569NEWT:4787NEWT:751585NEWT:113549NEWT:46503NEWT:180788NEWT:159749NEWT:1270NEWT:388919NEWT:130081NEWT:4784NEWT:360106NEWT:4785NEWT:360104NEWT:10117NEWT:401614NEWT:10116NEWT:1280NEWT:83333NEWT:83334NEWT:242718NEWT:83332NEWT:161NEWT:242715NEWT:2951803NEWT:46515NEWT:563924NEWT:100226NEWT:1263NEWT:176299NEWT:1654360NEWT:54126NEWT:75058NEWT:13616NEWT:13613NEWT:2852005NEWT:172NEWT:296543NEWT:173NEWT:316435NEWT:42157NEWT:165179NEWT:1034304NEWT:105023NEWT:866628NEWT:535026NEWT:749200NEWT:1036967NEWT:266264NEWT:272942NEWT:272943NEWT:1882682NEWT:145953NEWT:257309NEWT:33658NEWT:33657NEWT:203124NEWT:306254NEWT:230741NEWT:8296NEWT:117008NEWT:167748NEWT:1163394NEWT:645463NEWT:749696NEWT:986075NEWT:320549NEWT:990119NEWT:77216NEWT:1111708NEWT:11855NEWT:998086NEWT:228410NEWT:493760NEWT:93163NEWT:257313NEWT:3827NEWT:400772NEWT:257310NEWT:128161NEWT:930945NEWT:332521NEWT:106350NEWT:455045NEWT:29170NEWT:269796NEWT:54571NEWT:412754NEWT:9598NEWT:52389NEWT:2665964NEWT:1423772NEWT:51056NEWT:35815NEWT:53232NEWT:1235987NEWT:632138NCBITaxon:2509511NEWT:1639NEWT:188229NEWT:3818NEWT:432359NEWT:9103NEWT:715877NEWT:862238NEWT:29159NEWT:1155748NEWT:9593NEWT:8260NEWT:9595NEWT:2665958NEWT:246200NEWT:6087NEWT:145943NEWT:595536NEWT:1134822NEWT:240906NEWT:89920NEWT:3809NEWT:29158NEWT:44744NEWT:3879NEWT:1328881NEWT:411483NEWT:76336NEWT:3870NEWT:479437NEWT:884019NEWT:411490NEWT:169963NEWT:587NEWT:588NEWT:585NCBITaxon:43925NEWT:746128NEWT:212035NCBITaxon:1653394NEWT:1205NEWT:214693NEWT:1207NEWT:45609NEWT:239935NEWT:1680NEWT:280148NEWT:9172NEWT:2770979NEWT:112NEWT:423477NEWT:1277351NEWT:1594786NEWT:40366NEWT:3854NEWT:214687NEWT:1080228NEWT:411469NEWT:1679NEWT:333849NEWT:214684NEWT:1758543NEWT:569NEWT:411464NEWT:525283NEWT:411460NEWT:1328426NEWT:562NEWT:411470NEWT:10515NEWT:2094720NCBITaxon:2697049NEWT:294750NEWT:1663NEWT:214675NEWT:62141NEWT:65651NEWT:3848NEWT:3847NEWT:198466NEWT:327159NEWT:1045010NEWT:178876NEWT:1660NEWT:327160NEWT:573NEWT:1131757NEWT:571NEWT:142479NEWT:29595NEWT:241368NEWT:42528NEWT:1969471NEWT:9657NEWT:150596NEWT:30540NEWT:264483NEWT:439733NEWT:76777NEWT:30545NEWT:76773NEWT:1121114NEWT:663NEWT:1081927NEWT:1238993NEWT:67825NEWT:187878NEWT:1504802NEWT:1821314NEWT:103351NEWT:40354NEWT:1249668NEWT:426430NEWT:38033NEWT:37181NEWT:929439NEWT:9646NEWT:5286NEWT:7469NEWT:9643NEWT:9644NEWT:426428NEWT:63459NCBITaxon:446NEWT:2652157NEWT:2652158NEWT:40353NEWT:1276815NEWT:40324NEWT:588858NEWT:9638NEWT:9639NCBITaxon:11071NEWT:693977NEWT:242231NEWT:197221NEWT:528354NEWT:51453NEWT:1279085NEWT:28231NEWT:7460NEWT:504457NEWT:392227NEWT:1920175NEWT:1004024NEWT:103372NEWT:862751NEWT:470150NEWT:9627NEWT:1009714NEWT:73239NEWT:38018NEWT:226186NEWT:381518NEWT:659NEWT:30532NEWT:8782NEWT:30538NEWT:115357NEWT:5270NEWT:63436NEWT:28229NEWT:63433NEWT:13164NEWT:1601067NEWT:129554NEWT:40302NEWT:1249615NEWT:343232NEWT:343237NEWT:2664179NEWT:623NEWT:217219NEWT:7038NEWT:6192NCBITaxon:1639NEWT:767468NEWT:3915NEWT:1581419NCBITaxon:3570232NEWT:405534NEWT:9689NEWT:8355NEWT:633NEWT:9685NEWT:1218948NEWT:7029NEWT:9688NEWT:6182NEWT:9694NEWT:604162NEWT:1046723NEWT:186990NEWT:8364NEWT:6185NEWT:632NEWT:6183NEWT:1423800NEWT:630NCBITaxon:11019NEWT:334747NEWT:3907NEWT:3906NEWT:27315NEWT:61235NEWT:343691NEWT:1457551NEWT:15368NEWT:76717NEWT:13180NEWT:1491466NEWT:340188NEWT:170187NEWT:1755437NEWT:1042399NEWT:9681NEWT:1718NEWT:1719NEWT:692672NEWT:2697049NEWT:568813NEWT:1109443NEWT:267566NEWT:58042NEWT:7004NEWT:9669NCBITaxon:6073NEWT:1089448NEWT:1329349NEWT:1089444NEWT:607699NEWT:6161NEWT:206542NEWT:27337NEWT:575584NEWT:186536NEWT:257771NEWT:185687NEWT:3039NEWT:2706014NEWT:6549NEWT:8727NEWT:8726NEWT:8725NEWT:10090NEWT:8729NEWT:8720NEWT:5693NEWT:2186NEWT:8724NEWT:8723NEWT:283166NEWT:439334NEWT:8722NEWT:5697NEWT:6544NEWT:218192NCBITaxon:10114NEWT:2190NEWT:1685931NEWT:242619NEWT:557723NEWT:557722NEWT:160791NEWT:1353008NEWT:34073NEWT:402042NEWT:373995NEWT:5689NEWT:8715NEWT:544404NEWT:287535NEWT:1547922NEWT:2173NEWT:2175NEWT:1232801NEWT:5691NEWT:61674NEWT:2072580NEWT:669465NEWT:1117957NEWT:6526NEWT:8709NEWT:1064539NEWT:8707NEWT:1306274NEWT:5671NEWT:13146NEWT:6523NEWT:8700NEWT:1692259NEWT:1486917NEWT:2636997NEWT:1843183NEWT:5661NEWT:157592NEWT:3482NEWT:52714NEWT:51866NEWT:58002NEWT:13136NEWT:5660NEWT:5665NEWT:1179777NEWT:6997NEWT:5666NEWT:1746091NEWT:5664NEWT:2157NEWT:70125NEWT:146479NEWT:905079NEWT:1843192NEWT:206189NEWT:2160NEWT:295139NEWT:27779NEWT:181214NEWT:6108NEWT:1720309NEWT:9612NEWT:1286640NEWT:38865NEWT:3077NEWT:9615NEWT:6100NEWT:713604NEWT:3076NEWT:112273NEWT:13563NEWT:33178NEWT:1147787NEWT:39717NEWT:62977NEWT:2562269NEWT:1440772NEWT:45157NEWT:10040NEWT:8759NEWT:9605NEWT:9606NEWT:27717NEWT:641501NEWT:9601NEWT:8752NEWT:34038NEWT:9604NEWT:8756NEWT:74940NEWT:13551NEWT:10041NEWT:9600NEWT:1450511NEWT:439375NEWT:1857323NEWT:890382NEWT:174934NEWT:179392NEWT:2823525NEWT:115778NEWT:1538186NEWT:82996NEWT:1659668NEWT:227086NEWT:3055NEWT:195883NEWT:1450520NEWT:1042311NEWT:1123352NEWT:741258NEWT:82525NEWT:29920NEWT:82528NEWT:235909NEWT:47311NCBITaxon:813NEWT:127785NEWT:708248NEWT:47314NEWT:104660NEWT:652611NEWT:1417983NEWT:94993NEWT:6550NEWT:10068NEWT:8732NEWT:763037NEWT:1250232NEWT:1052588NEWT:1377NEWT:3555NEWT:71647NEWT:260201NEWT:35554NCBITaxon:12939NEWT:935692NEWT:1322343NEWT:32046NEWT:2222NEWT:59523NEWT:544496NEWT:1736657NEWT:59529NEWT:32049NEWT:1392696NEWT:762376NEWT:45351NEWT:445974NEWT:43179NEWT:180454NEWT:3544NEWT:5722NEWT:7901NEWT:32051NEWT:10245NEWT:55153NEWT:2944139NEWT:10243NEWT:351581NEWT:43186NEWT:70779NEWT:428146NEWT:889247NEWT:498019NEWT:1351NEWT:1438992NEWT:1352NEWT:32025NEWT:2649997NEWT:1147161NEWT:1645733NEWT:43150NEWT:69781NEWT:85831NEWT:263737NEWT:1333499NEWT:5702NEWT:95648NEWT:1349NEWT:67593NEWT:866555NEWT:100787NEWT:1401257NEWT:44491NEWT:27933NEWT:556484NEWT:94328NEWT:7956NEWT:7955NEWT:7959NEWT:645159NEWT:2261NEWT:94323NEWT:31156NEWT:3112NEWT:8801NEWT:4442NEWT:192875NEWT:1214915NEWT:1214916NEWT:284218NEWT:1316931NEWT:45796NEWT:511145NEWT:213401NEWT:931281NEWT:4432NEWT:5762NEWT:5763NEWT:118099NEWT:32019NEWT:658457NEWT:420247NEWT:35525NEWT:1424337NEWT:295358NEWT:2246NEWT:2652724NEWT:5757NEWT:68415NCBITaxon:4563NEWT:5755NEWT:44447NEWT:752555NEWT:39097NEWT:347495NEWT:5759NEWT:1736231NEWT:1392NEWT:35974NEWT:2242NEWT:1396NEWT:1324588NEWT:286NEWT:391619NEWT:470921NEWT:287NEWT:1367269NEWT:633149NEWT:1149786NEWT:10239NEWT:68895NEWT:3567NEWT:68888NEWT:4897NEWT:5744NEWT:72901NEWT:213863NEWT:1905158NEWT:55571NEWT:35500NEWT:1235816NEWT:2041044NEWT:3562NEWT:4896NEWT:5740NEWT:1262161NEWT:343904NEWT:1314781NEWT:1390NEWT:11557NEWT:294NEWT:1773NEWT:82380NEWT:935293NEWT:375146NEWT:471876NEWT:1772NEWT:1090134NEWT:263NEWT:11988NEWT:400667NEWT:408169NEWT:36809NEWT:47946NEWT:459758NEWT:105135NEWT:1764NEWT:39087NEWT:109974NEWT:413996NEWT:243277NEWT:7067NEWT:586722NEWT:243273NEWT:1986198NEWT:274NEWT:7070NCBITaxon:287NEWT:408172NEWT:59919NEWT:408170NEWT:283734NEWT:7074NEWT:1436733NEWT:42229NEWT:1247411NEWT:9238NEWT:13708NEWT:333760NEWT:34607NEWT:1513458NEWT:1233681NEWT:2212966NCBITaxon:40559NEWT:506599NEWT:81077NEWT:84588NEWT:1279007NEWT:85433NEWT:572545NEWT:65349NEWT:300852NEWT:564933NEWT:508771NEWT:1121405NEWT:580165NEWT:253NCBITaxon:2759NEWT:93061NEWT:93062NEWT:1284813NEWT:34613NEWT:548470NEWT:7054NCBITaxon:4932NEWT:1748NEWT:108673NEWT:2764168NEWT:943274NEWT:1488406NEWT:644223NEWT:1263082NEWT:272623NEWT:1288389NEWT:272624NEWT:886559NEWT:55521NEWT:118499NEWT:1130798NEWT:55529NEWT:256136NEWT:476272NEWT:195051NEWT:3988NEWT:561007NEWT:649908NEWT:1001135NEWT:147828NEWT:3981NEWT:3983NEWT:203696NEWT:223283NEWT:352472NEWT:235NEWT:505235NEWT:55518NEWT:97441NEWT:1154756NEWT:1202531NEWT:1202532NEWT:360094NEWT:1408223NEWT:1408224NEWT:29695NEWT:41364NEWT:1311NEWT:1313NEWT:1218097NEWT:1080348NEWT:1314NEWT:39491NEWT:212142NCBITaxon:5811NEWT:3972NEWT:1499105NEWT:686NEWT:192812NEWT:408188NEWT:571256NEWT:40483NEWT:688333NEWT:1119529NEWT:1303NCBITaxon:548681NEWT:318586NCBITaxon:5820NEWT:272634NEWT:198107NEWT:1979401NEWT:9267NEWT:155892NEWT:691NEWT:637910NEWT:28384NEWT:167879NEWT:1872122NEWT:1308NEWT:7091NEWT:1034015NEWT:760568NEWT:141262NEWT:1737068NEWT:1813NEWT:4087NEWT:9778NEWT:306NEWT:505693NEWT:303NEWT:97477NEWT:7111NEWT:113287NEWT:347515NEWT:79923NEWT:435258NEWT:6269NEWT:4090NEWT:4092NEWT:4093NEWT:786NEWT:4096NEWT:208895NEWT:941442NEWT:536088NEWT:311553NEWT:1226408NEWT:43984NEWT:7108NEWT:367110NEWT:40479NEWT:43989NEWT:4076NEWT:142615NEWT:317NEWT:885319NEWT:293939NEWT:497515NEWT:885318NEWT:39488NEWT:1268285NEWT:4081NEWT:273068NEWT:1316582NEWT:227166NEWT:98334NEWT:231663NEWT:4084NEWT:63577NEWT:7574NEWT:1715256NEWT:30640NEWT:348824NEWT:929793NEWT:1507179NEWT:29204NEWT:114155NEWT:4072NEWT:1337056NEWT:4073NEWT:634955NEWT:6239NEWT:102169NEWT:208893NEWT:4054NEWT:301301NEWT:98351NEWT:1263854NEWT:118503NEWT:2059687NEWT:160488NEWT:63558NEWT:61376NEWT:207559NEWT:107401NEWT:85057NEWT:985076NEWT:1215323NCBITaxon:565995NEWT:7159NEWT:267671NEWT:72491NEWT:7160NEWT:8496NEWT:7165NEWT:1257118NEWT:1387333NEWT:8010NEWT:1315282NEWT:7162NEWT:1859NEWT:27448NEWT:2708NEWT:38111NEWT:235612NEWT:243232NEWT:243230NEWT:936053NEWT:1080772NEWT:8479NEWT:8485NEWT:119856NEWT:72000NEWT:119857NEWT:49240NEWT:161398NEWT:89426NEWT:2893330NCBITaxon:3707NEWT:391295NEWT:1170828NEWT:104395NEWT:93934NEWT:9315NEWT:6289NEWT:38568NEWT:6287NEWT:38569NEWT:727NEWT:9796NEWT:118562NEWT:725NEWT:7137NEWT:469008NEWT:9321NEWT:596153NEWT:8472NEWT:1836NCBITaxon:10298NEWT:1652998NEWT:105231NEWT:104385NEWT:74649NEWT:1037924NEWT:206672NEWT:9788NEWT:4097NEWT:9305NEWT:436113NEWT:71139NEWT:9785NEWT:6279NEWT:1195774NEWT:9793NCBITaxon:780NCBITaxon:1502NEWT:6282NEWT:27457NEWT:4006NEWT:1872635NCBITaxon:5476NEWT:113208NEWT:6669NEWT:1215360NEWT:89453NEWT:1114301NEWT:51515NEWT:13249NEWT:1566338NEWT:588596NEWT:51511NEWT:8845NEWT:7998NEWT:419610NEWT:5334NEWT:382352NEWT:413071NCBITaxon:10239NEWT:332097NCBITaxon:714NEWT:1076620NEWT:11051NEWT:89462NEWT:452680NEWT:8839NEWT:4472NEWT:2758385NEWT:171101NEWT:714NEWT:5322NEWT:34199NEWT:568996NEWT:421932NEWT:312017NEWT:576131NEWT:553470NCBITaxon:10243NEWT:284593NEWT:100392NEWT:655819NEWT:5315NEWT:11082NEWT:265872NEWT:59463NEWT:337330NEWT:2285NEWT:2287NEWT:6645NEWT:251229NEWT:981087NEWT:180066NEWT:46147NCBITaxon:6312NEWT:11072NEWT:174633NEWT:52830NEWT:1416333NEWT:35024NEWT:135461NEWT:7962NEWT:99287NEWT:1817808NEWT:145262NEWT:145263NEWT:296587NEWT:694569NEWT:9739NEWT:111069NEWT:1379791NEWT:51953NEWT:57267NEWT:3197NEWT:13686NEWT:2750454NEWT:264561NEWT:1402135NEWT:36329NEWT:62615NEWT:1555636NEWT:46124NEWT:1333550NEWT:646099NEWT:72407NEWT:352914NEWT:349741NEWT:409859NEWT:157295NEWT:1263871NEWT:509169NEWT:6210NEWT:3051137NEWT:9721NEWT:137221NEWT:565050NEWT:409860NEWT:92683NEWT:1298968NEWT:5353NEWT:1034809NEWT:452659NEWT:1193501NEWT:51930NEWT:1193502NEWT:6689NEWT:194675NEWT:298315NEWT:392547NEWT:46105NEWT:104782NEWT:10181NEWT:9704NEWT:1049056NEWT:698936NEWT:13216NEWT:1009874NEWT:4498NEWT:8855NEWT:11034NEWT:3168NEWT:10185NEWT:78168NEWT:521001NEWT:192011NEWT:340912NEWT:1813887NEWT:224911NEWT:1090946NCBITaxon:11552NEWT:267608NEWT:334249NEWT:184922NEWT:6703NEWT:1498NEWT:2NEWT:35670NEWT:511693NEWT:5855NEWT:4528NEWT:35677NEWT:136841NEWT:1493NEWT:10376NEWT:1496NEWT:3674NEWT:5851NEWT:660469NEWT:935568NEWT:1365186NEWT:1813019NEWT:45474NEWT:48500NEWT:4513NEWT:5843NEWT:110205NEWT:1117645NEWT:376741NEWT:310915NCBITaxon:10407NEWT:1000364NEWT:10360NEWT:1403536NEWT:1427524NEWT:47664NEWT:260799NEWT:317548NEWT:106198NEWT:2323NEWT:3654NEWT:237561NEWT:5833NEWT:70415NEWT:3659NEWT:59620NEWT:499229NEWT:31298NEWT:1204162NEWT:1532734NEWT:635003NEWT:82688NEWT:5823NEWT:5821NEWT:44139NCBITaxon:4895NEWT:570417NCBITaxon:4896NEWT:675512NEWT:315393NEWT:3649NEWT:28903NEWT:325176NEWT:910263NEWT:28909NEWT:3641NEWT:79698NEWT:28901NCBITaxon:5796NEWT:137732NEWT:12993NEWT:398580NEWT:4565NEWT:1264690NEWT:515619NEWT:170721NEWT:34305NEWT:77020NEWT:1908323NEWT:648794NEWT:83558NEWT:44586NEWT:626528NEWT:139927NEWT:4558NEWT:5888NEWT:431241NEWT:4550NEWT:4555NEWT:443226NEWT:144036NEWT:144030NEWT:288705NEWT:392815NEWT:3217NEWT:4547NEWT:3218NEWT:556182NEWT:374990NEWT:36941NEWT:1432059NEWT:154293NEWT:156471NEWT:3694NEWT:5875NEWT:156476NEWT:4543NEWT:210007NEWT:1857017NEWT:10359NEWT:1358430NEWT:10358NEWT:1381693NEWT:1735272NEWT:109298NEWT:317513NEWT:707678NEWT:580240NEWT:294128NEWT:11676NEWT:1917265NEWT:55210NEWT:718308NEWT:4530NEWT:5861NEWT:44577NEWT:1895NEWT:2558360NEWT:215358NEWT:64152NEWT:4924NEWT:2748NEWT:8049NEWT:33892NEWT:99931NEWT:9378NEWT:990346NEWT:100816NEWT:192952NEWT:1640346NCBITaxon:1313NEWT:29385NEWT:44544NEWT:529818NEWT:400540NEWT:382NEWT:4911NEWT:152480NEWT:129249NEWT:1888NEWT:1077286NEWT:943129NEWT:131567NEWT:1221594NEWT:10760NEWT:1077281NEWT:1524260NEWT:227321NEWT:192944NEWT:492670NEWT:281677NEWT:106590NEWT:260710NEWT:4918NEWT:1162296NEWT:106592NEWT:596645NEWT:46704NEWT:42345NEWT:482428NEWT:1187947NEWT:4903NEWT:10312NCBITaxon:1773NEWT:323848NEWT:190304NEWT:1432499NEWT:8030NEWT:246432NEWT:246437NEWT:36909NEWT:4909NEWT:443256NEWT:1279365NEWT:759272NEWT:1182263NEWT:943146NEWT:646532NEWT:2711NEWT:537457NEWT:479249NEWT:435623NEWT:33889NCBITaxon:131567NEWT:10306NEWT:12967NEWT:8022NEWT:12966NEWT:42353NEWT:593117NEWT:3633NEWT:319761NEWT:3635NEWT:5811NEWT:86662NEWT:180923NEWT:2050920NEWT:1451NEWT:198215NEWT:200298NEWT:12916NEWT:1400870NEWT:343NEWT:84005NEWT:225117NEWT:34708NEWT:8090NEWT:537012NEWT:5801NEWT:43665NEWT:5802NEWT:4952NEWT:1266464NEWT:367830NEWT:1093790NEWT:178616NEWT:95145NEWT:358NEWT:375451NEWT:54788NEWT:357NEWT:74381NEWT:2010198NEWT:167539NCBITaxon:186538NEWT:457428NEWT:106178NEWT:316275NEWT:84023NEWT:589904NEWT:559292NEWT:316273NEWT:2762NEWT:1174673NEWT:28035NEWT:1313166NEWT:690307NCBITaxon:138NEWT:29365NEWT:28038NEWT:1422NEWT:84030NEWT:1423NEWT:4932NEWT:1205903NEWT:3603NEWT:2756NEWT:2759NEWT:38293NEWT:1428NEWT:339NEWT:2751NEWT:330NEWT:139077NEWT:391904NEWT:12922NEWT:316277NEWT:163159NEWT:1306413NEWT:2813599NEWT:518766NEWT:2664373NEWT:190802NEWT:1213463NEWT:7234NEWT:9417NEWT:1216979NEWT:9895NEWT:7237NEWT:5059NEWT:55601NEWT:31631NEWT:509924NEWT:28450NEWT:115104NEWT:5061NEWT:7240NEWT:8570NEWT:127569NEWT:5062NEWT:1408434NEWT:1241935NEWT:220668NEWT:3428464NEWT:9407NEWT:7227NEWT:193079NEWT:679895NEWT:9402NEWT:415540NEWT:336722NEWT:675060NEWT:416870NEWT:334542NEWT:313625NEWT:51240NEWT:27592NEWT:5052NEWT:227289NEWT:1985738NEWT:7215NEWT:196139NEWT:9874NEWT:5037NEWT:651182NEWT:2172103NCBITaxon:59201NEWT:7220NEWT:1876254NEWT:434271NEWT:1915NEWT:747679NEWT:66712NEWT:42752NEWT:746360NEWT:89764NEWT:543734NEWT:53408NEWT:49390NEWT:9870NEWT:256648NEWT:1261557NEWT:435590NEWT:1902NEWT:208526NEWT:1908NEWT:1169740NEWT:217459NEWT:216129NEWT:1245012NEWT:171250NEWT:528135NEWT:198732NEWT:1637254NCBITaxon:38727NEWT:176946NEWT:74790NEWT:254472NEWT:2829NEWT:126279NEWT:1228997NEWT:1428006NEWT:62335NEWT:366581NEWT:757417NEWT:216599NEWT:216595NEWT:40559NEWT:51208NEWT:216597NEWT:42736NEWT:1607839NEWT:194366NEWT:1283300NEWT:1218707NEWT:1204551NEWT:99586NEWT:228577NEWT:2060328NEWT:48038NEWT:392021NEWT:436486NEWT:51655NEWT:1933298NEWT:260707NEWT:121845NEWT:8595NEWT:7263NEWT:280754NEWT:186763NEWT:447135NEWT:185431NEWT:216591NEWT:29760NEWT:260704NEWT:703612NEWT:260705NEWT:1202347NEWT:1295743NEWT:546805NEWT:1505907NEWT:1216981NEWT:1249885NEWT:1972855NEWT:853NEWT:7244NEWT:1415167NEWT:36036NCBITaxon:662NEWT:9430NEWT:851NEWT:71251NEWT:208963NEWT:208964NEWT:181088NEWT:48498NEWT:669202NEWT:1193806NEWT:6306NEWT:1250006NEWT:4120NEWT:820NEWT:821NEWT:37334NCBITaxon:10357NEWT:2040765NCBITaxon:10358NCBITaxon:10359NEWT:1203258NEWT:49317NEWT:1899318NEWT:696811NEWT:9808NEWT:839NEWT:9803NEWT:1097670NEWT:92519NEWT:37347NEWT:943925NEWT:4111NEWT:37349NEWT:4113NEWT:837NEWT:640459NEWT:72568NEWT:8954NEWT:36015NEWT:51641NEWT:35168NEWT:81866NEWT:334147NEWT:1262469NEWT:555778NEWT:277944NEWT:48479NEWT:61435NEWT:627025NEWT:1097677NEWT:375939NEWT:712938NEWT:3258NEWT:112018NEWT:1906951NEWT:101364NEWT:52945NEWT:4100NEWT:1159556NEWT:1076NEWT:4102NEWT:1028688NEWT:4101NEWT:6763NEWT:803NEWT:29722NEWT:37319NEWT:419947NEWT:2847306NEWT:184545NEWT:468911NEWT:13373NEWT:266834NEWT:817NEWT:7604NEWT:6756NEWT:818NEWT:135588NEWT:1061NEWT:4571NEWT:29719NEWT:6754NEWT:452589NEWT:509068NEWT:2794344NEWT:4577NEWT:813NEWT:1365218NEWT:337677NEWT:2086510NEWT:1042986NEWT:1911079NEWT:69373NEWT:427577NEWT:264203NEWT:1480154NEWT:9858NEWT:9859NEWT:512623NEWT:1274414NEWT:2907833NEWT:38626NEWT:10298NEWT:10299NEWT:1087439NEWT:9852NEWT:9860NEWT:660025NEWT:61408NEWT:1355477NEWT:90371NEWT:55194NEWT:2907829NEWT:4153NEWT:11137NEWT:1320353NEWT:278839NEWT:59552NEWT:35128NEWT:39966NEWT:7668NEWT:2929635NEWT:58228NEWT:915099NEWT:8996NEWT:1143193NEWT:681376NEWT:687914NEWT:1122233NEWT:277988NEWT:1199150NEWT:859313NEWT:59540NEWT:52904NEWT:9838NEWT:9839NEWT:546414NEWT:11167NEWT:9835NEWT:7650NEWT:4146NEWT:5478NEWT:6326NEWT:7656NEWT:5476NEWT:5477NEWT:1882945NEWT:746707NEWT:299767NEWT:28835NEWT:1206781NEWT:5480NEWT:1274432NEWT:222863NEWT:2053667NEWT:859321NEWT:1274426NEWT:105751NEWT:9825NEWT:1274423NEWT:393765NEWT:104421NEWT:39946NEWT:9823NEWT:95602NEWT:6313NEWT:314539NEWT:39947NEWT:718274NEWT:1274420NEWT:859314NEWT:578458NEWT:605200000-0001-6059-198X